SS

Dr. Surya Kanta Swain

Amity University Kolkata, K.K. University Nalanda, Kaziranga University

Research areas: Pharmacology, Toxicology and Pharmaceutics · Pharmaceutical Science · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Nanoparticle-Based Drug Delivery

ORCID iD 0000-0002-1485-343X

About

Dr. Surya Kanta Swain is a distinguished academic leader, researcher, and administrator with over 19 years of experience spanning academia, research, industry, and institutional leadership. He currently serves as Professor and Head, Amity Institute of Pharmacy, Head (R & D Cell) Amity University Kolkata, West Bengal, India. Previously, he held key leadership positions as Dean (Pharmacy & Research), K.K. University, and Dean of Research, Principal (Pharmacy), and Associate Dean, School of Health Sciences, The Assam Kaziranga University, Assam, India.

A visionary academic administrator, Dr. Swain has established 30 state-of-the-art laboratories, initiated an AMC Centre under the Pharmacovigilance Programme of India (PvPI), enhanced the B.Pharm intake from 60 to 100, introduced B.Pharm Lateral Entry, and launched five industry-oriented postgraduate programmes tailored to the healthcare needs of Northeast India. He has also played a pivotal role in designing outcome-based curricula aligned with NEP and professional standards.

His research focuses on Quality by Design (QbD)-enabled advanced drug delivery systems, including self-emulsifying, mucoadhesive, gastro-retentive, transdermal, and nanoparticulate formulations. He has successfully secured a SERB-CRG research grant of ₹60 lakh and has submitted four externally funded projects worth over ₹3.5 crore to agencies including SERB, ICMR, and BIRAC.

Dr. Swain has authored 150+ high-impact research publications in reputed SCI-E, Scopus, Web of Science, and UGC CARE journals published by Springer, Elsevier, Taylor & Francis, Bentham Science, and others. His scholarly contributions have earned 3950 + Google Scholar citations (H-index: 29) and 2327+ Scopus citations (H-index: 23). He has also edited 10 National textbooks, authored 8 international books, contributed 45 book chapters, and holds 2 granted Indian patent with 2 published patents.

An accomplished editor and reviewer, Dr. Swain serves as Editor-in-Chief of the Indian Journal of Pharmacy and Pharmacology and is associated with the editorial and reviewer boards of 100+ international journals. He is an approved Ph.D. supervisor, academic expert, examiner, evaluator, and Board of Studies member for several leading universities across India. To date, he has guided 4 Ph.D. scholars, is currently supervising 8 Ph.D. scholars, and has mentored over 100 postgraduate, undergraduate, and Pharm.D research projects.

Dr. Swain has received numerous prestigious recognitions, including the Bharat Gaurav Puraskar (2024), Commendable Editor-in-Chief Award (2022), Emerging Leader in Health & Medical Sciences Award, Bentham Science Publisher Ambassador Award, and several national research excellence awards.

A sought-after invited speaker and resource person, he has delivered 100+ keynote lectures, expert talks, and invited presentations in AICTE, DST, DBT, PCI, ICMR, and UGC-sponsored conferences, FDPs, workshops, and scientific forums. He is an active life member of leading professional bodies, including APTI, IPA, IPGA, ISPOR, FIC, and HAB, and contributes to national and international research, academic quality assurance, and policy initiatives.

Employment

  • Amity University Kolkata Professor & Head of the Institute
    2024 - Present
  • K.K. University Nalanda Dean & Professor
    2022 - 2024
  • Kaziranga University Professor, Dean Research, Associate Dean and Head (Pharmacy)
    2020 - 2022
  • SIMS Group of Institutions Professor and Vice Principal
    2018 - 2020
  • SIMS Group of Institutions Associate Professor and HoD
    2015 - 2018
  • 2008 - 2015

Education

Education history is unavailable.

Projects & Funding

  • Understanding the role of serine hydrolases in epithelial to mesenchymal transition (EMT) during hepatocellular carcinoma (HCC) Science and Engineering Research Board (SERB-DST)
    2023 - 2026

Publications (77)